Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
about
Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionObesity-Related Digestive Diseases and Their PathophysiologyAssociation of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-AnalysisMetabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare DataRisk factors and chemoprevention in Barrett's esophagus--an update.The risk of Barrett's esophagus associated with abdominal obesity in males and females.The role of adiponectin in cancer: a review of current evidence.Circulating Inflammatory Cytokines Are Associated With the Risk of Barrett's Esophagus in Western Persons.Pathophysiological mechanisms linking obesity and esophageal adenocarcinomaThe role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagusMechanisms of obesity-induced gastrointestinal neoplasiaThe feasibility of an exercise intervention in males at risk of oesophageal adenocarcinoma: a randomized controlled trial.Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.Associations of Circulating Gut Hormone and Adipocytokine Levels with the Spectrum of Gastroesophageal Reflux Disease.Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux DiseaseEpidemiology, Diagnosis, and Management of Esophageal AdenocarcinomaCurrent status and future perspectives on the etiology of esophageal adenocarcinoma.Associations of Serum Adiponectin and Leptin With Barrett's Esophagus.Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center.Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control studyAssociations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.Gastroesophageal reflux and rhinosinusitis.Impact of anthropometric measures and serum leptin on severity of gastroesophageal reflux disease.Obesity and Oesophageal Cancer.Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.Identification of key pathways and genes in Barrett's esophagus using integrated bioinformatics methods.Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus.Globular adiponectin inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation via adiponectin receptor 2-mediated suppression of UHRF1.Barrett's esophagus
P2860
Q27026253-0DE1E32C-B78E-42AE-A13D-95A816E31AD2Q28073381-05A324BC-5C04-47FC-A432-54B9112B9BC9Q28087021-81884B11-31B8-479D-AF83-D9BEF2601287Q30786254-D988A974-E0A8-4409-A5D6-9DB11D4FFAC6Q34201351-30BA2C48-A44B-4771-B1B2-CAE745156EC0Q34266800-035AA55C-23B6-4145-B57C-72C8406983F8Q34271986-31ADFBAB-25C4-46EC-AFB4-320341CC8F28Q34377218-4C38A0B9-865C-474C-9965-55729BA67969Q34508880-4B7E3F6F-171C-4D10-86FD-A2E95C87C337Q34542075-6E8CB31E-4F48-4180-BAEC-E0D5C68BC725Q35062195-DF3977E2-E43E-4B17-90B5-937292FA5FFEQ35113330-939B185D-9A7D-4E7C-8C08-EE31EF9E1103Q35185711-EC82CB0D-3180-495B-A45B-6309F77696A7Q35823259-0F134F68-7CF1-4B21-9EA5-4230BCFB47E2Q35890113-37385D97-8782-4711-B327-897860D9B783Q35893814-9D792300-DB08-44FF-A23C-7886A1C92133Q35972032-41BB63C1-0883-46B9-B6E2-DACB527A8058Q36932731-93B640A2-D890-4FDE-AF83-EAFBE242BC1BQ37042894-A3331816-2732-4368-8D6A-1CAB49A25341Q37206840-892B28BA-5FFF-42BF-8230-98FBB5BBB526Q37398529-38A75049-CDBA-4E1B-9569-4D632C09AF6BQ37416283-EA772D39-ADBD-4D7B-9211-FDF0FD126B71Q37505223-22A54774-F77F-4B58-8BF6-8EAF27874ED0Q37557505-CA925603-CD50-4535-B6FE-78C8BCB7ECB0Q38078261-E90AA5BA-D159-4EDA-9A61-31AC9168F98DQ38855731-715DF6A1-EF24-4886-86B0-5C651FFED303Q39026649-300B39DD-500B-4B7A-A2C1-E86677FFBB20Q41325570-0F237AF8-E82C-43B3-B716-0139E209105DQ47275569-F5229587-6CBF-45C2-909E-FD3F46F3DC29Q48504657-7F5619A8-E0EB-4386-9B07-DED962CF8699Q51101393-0CBD7356-9EA0-42B5-A900-107F2EEF4FC3Q57742664-AA870476-E3B1-496B-AC72-9F09149F4215
P2860
Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@ast
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@en
type
label
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@ast
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@en
prefLabel
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@ast
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@en
P2093
P2860
P356
P1433
P1476
Serum leptin and adiponectin l ...... the gastroesophageal junction.
@en
P2093
Elizabeth A Kirk
Mary P Bronner
Olivia M Thompson
Shirley A A Beresford
Thomas L Vaughan
P2860
P304
P356
10.1038/OBY.2009.508
P577
2010-01-28T00:00:00Z